Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.

Park, Jihyun; Brekke, Dona R; Bratincsak, Andras

Park, Jihyun; Brekke, Dona R; Bratincsak, Andras.

Park J; Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
Brekke DR; Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
Bratincsak A; Pediatric Cardiology, Hawaii Pacific Health Medical Group, Honolulu, Hawaii, USA.

Cardiol Young ; 32(1): 146-149, 2022 Jan.

Article in English | MEDLINE | ID: covidwho-1283658

ABSTRACT

ABSTRACT

Two adolescent males presented within 3 days after the first and second dose of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST segment elevation, and enhancement of the myocardium in cardiac MRI suggested myocarditis. Left ventricular function remained normal, symptoms resolved, and patients were discharged in 4 days. BNT162b2 vaccine may be associated with self-limited myocarditis in youth.

Subject(s)

COVID-19; Myocarditis; Adolescent; BNT162 Vaccine; COVID-19 Vaccines; Chest Pain/diagnosis; Chest Pain/etiology; Humans; Male; Myocarditis/diagnosis; Myocarditis/etiology; Vaccination/adverse effects; Vaccines, Synthetic; mRNA Vaccines

Keywords

COVID-19; ST segment elevation; myocarditis; troponin; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study Topics: Vaccines Limits: Adolescent / Humans / Male Language: English Journal: Cardiol Young Journal subject: Vascular Diseases / Cardiology / Pediatrics Year: 2022 Document Type: Article Affiliation country: S1047951121002547

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google